Table 1.
Reconstruction of ocular surface using cultured bone marrow-derived mesenchymal stem cells.
Author, Year, (Reference) | Cell Source | Methods | LSCD Model | Follow-up Time | Evaluation | Results |
---|---|---|---|---|---|---|
Ma et al. 2006 [35] | Bone Marrow-Derived MSCs; Human | Cultured on AM carrier; Transplanted (n = 16); Control groups: 1) transplanted with fibroblast cells on AM (n = 8) and 2) transplanted with only AM (n = 7) |
Rats; Disc paper saturated with 1 N NaOH onto cornea | 4 weeks | Slit lamp evaluation; Histology; IH | Reconstruction in 100% (16/16) of animals; Cornea completely transparent in 56.3% (9/16) of animals; Neovascularization detected within 2 mm and over 2 mm in 37.5% (6/16) and 12.5% (2/16) of animals, respectively; No complications |
Ye et al. 2006 [39] | Bone Marrow-Derived MSCs; Rabbit | Cultured in α-MEM; IV injection; Four groups:
|
Rabbits; Filter paper saturated with 1 N NaOH onto cornea | 1 month | Slit lamp evaluation; IH | Reconstruction in 100% (15/15) of animals in Group 2; Cornea more clear in group 2 compared with other groups; Neovascularization appeared on day 14 in Group 2; No complications |
Gu et al. 2009 [33] | Bone Marrow-Derived MSCs; Rabbit | Cultured on fibrin carrier; Transplanted (n = 10); Control: eyes transplanted with only fibrin graft gel (n = 10) |
Rabbits; Cornea treated with n-heptanol | 4 weeks | Slit lamp evaluation; Histology; FC; IF | Reconstruction in 100% (10/10) of animals; Iris partially clear in 30% (3/10) and completely obscure in 70% (7/10) of animals; Neovascularization detected over 3 mm from the limbus in 80% (8/10) of animals; No complications |
Omoto et al. 2009 [36] | Bone Marrow-Derived MSCs; Human | Cultured in α-MEM; Carrier-free sheets transplanted; Control: no transplantation; Number of animals not reported |
Rabbits; Cornea treated with n-heptanol | 4 weeks | Slit lamp evaluation; Histology; IH; RT-PCR | Reconstruction of corneal epithelium successful; Corneal clarity: no data; Neovascularization: no data; No complications |
Jiang et al. 2010 [34] | Bone Marrow-Derived MSCs; Rat | Cultured on AM carrier; Three groups:
|
Rats; Filter paper saturated with 1 N NaOH onto cornea | 10 weeks | Slit lamp evaluation; Histology; CLCM; SEM; FC; IF; IH | Reconstruction in 75% (9/12) of animals in group 3; Cornea completely transparent in 75% (9/12) of animals; Neovascularization limited within 2 mm of the limbus; No complications |
Zajicova et al. 2010 [40] | Bone Marrow-Derived MSCs; Mouse | Cultured on nanofiber scaffold carrier; Co-transplantation of LSC and MSCs; Control: normal eyes; Number of animals not reported |
Mice; Epithelial debridement with a needle | 2 weeks | Slit lamp evaluation; CLCM; FC; RT-PCR | Significantly inhibited local inflammatory reactions and supported healing process; Corneal clarity: no data; Neovascularization: no data; No complications |
Reinshagen et al. 2011 [37] | Bone Marrow-Derived MSCs; Rabbit | Cultured in DMEM; Three groups:
|
Rabbits; Cornea treated with n-heptanol | 6 months | Slit lamp evaluation; Histology; IH | Reconstruction in 100% (6/6) of animals in Group 1; Improved corneal clarity; Neovascularization of the entire cornea in all animals; No complications |
Rohaina et al. 2014 [38] | Bone Marrow-Derived MSCs; Human | Cultured on AM carrier; Transplanted (n = 4); Control groups:
|
Rats; Disc paper saturated with 1 N NaOH onto cornea | 8 weeks | Slit lamp evaluation; Histology; IH; OCT; RT-PCR | Reconstruction in 100% (4/4) of animals; Moderate corneal clarity; Minimal vascularization; No complications |
AM, amniotic membrane; BM, bone marrow; CFE, colony-forming efficiency; CLCM, confocal laser corneal microscopy; CP, cyclophosphamide; CSCs, corneal stromal cells; FC, flow cytometry; IH, immunohistochemistry; IF, immunofluorescence; IV, intravenous; LEC, limbal epithelial cells; LSC, limbal stem cells; LSCD, limbal stem cell deficiency; MSCs, mesenchymal stem cells; OCT, optical coherence tomography; RT-PCR, reverse transcriptase polymerase chain reaction; SEM, scanning electron microscopy.